耐性高血圧に対するアルドステロン合成酵素阻害剤: 薬理学的洞察 - 系統的レビュー
Arrigo F G Cicero1,2, Giuliano Tocci3, Ashot Avagimyan4
1Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Sant' Orsola-Malpighi Hospital - University of Bologna, Via Massarenti, 9 - 40138, Bologna, Italy.
Drugs
|August 30, 2025
まとめ
アルドステロン合成阻害剤 (ASI) は,特にアルドステロン濃度が高い患者の血圧を下げることで,抵抗性高血圧 (RHT) の治療に有望である. 個々の要因に基づいて個別化された治療は,RHTの結果を改善する可能性があります.
科学分野:
- 薬理学について
- 腎臓科
- 心臓病科
背景:
- 抵抗性高血圧 (RHT) は,高アルドステロン症を含む複数の原因を持つ複雑な状態です.
- アルドステロンの値上昇は,患者のサブセットでRHTの病理生理学に有意に寄与する.
研究 の 目的:
- アルドステロン合成阻害剤 (ASI) の薬動性を体系的に検討する.
- RHTの管理のためのASIの治療の可能性を評価する.
主な方法:
- 体系的な文献検索により,ASIに関する臨床試験と薬理学的研究が特定されました.
- 研究された主要なASIには,バックスドロスタット,デックスファドロスタット,ロルンドロスタット,LY3045697,およびオシロドロスタットが含まれています.
主要な成果:
- 診療室での血圧と24時間出院中の血圧の有意な低下を示した.
- RHTにおけるアルドステロンの役割を確認した.
- ASIは,異なる代謝経路,選択性プロファイル,および薬物動態特性を有する.
結論:
- アルドステロン合成酵素阻害剤は,RHTの潜在的な治療法です.
- 腎機能,ナトリウム摂取量,および併発症を考慮した個別化された治療戦略は,RHT患者のASI有効性と耐性を最適化するために不可欠です.
関連する概念動画
Antihypertensive Drugs: Direct Renin Inhibitors
817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Angiotensin II Receptor Blockers
911
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
911
Antihypertensive Drugs: Potassium-Sparing Diuretics
751
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
751
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
871
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
871
Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483


